Six serious injuries and one death
TeGenero, a development stage pharmaceutical company you never heard of before their drug trial almost killed six healthy volunteers, has declared bankruptcy.
July 11, 2006The unforeseeable adverse reactions caused by TGN1412 in the TGN1412-HV phase 1 trial have made it impossible to attract the investment necessary for the company to continue operations.